CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $2.48B, above the global median of $1.18B
- FinancialsAltman Z-Score 2.93: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.48BUSDvs all stocks (USD)
Revenue (TTM)
766.29MUSDvs all stocks (USD)
Profit Margin
-6.77%vs Diagnostics & Research peers
Beta
1.75xvs all stocks
52-Week Change
148.77%vs all stocks
Market Capitalization
2.48BUSDvs all stocks (USD)
Enterprise Value
2.79BUSDvs all stocks (USD)
Forward P/E
57.16xvs Diagnostics & Research peers
Price to Sales (TTM)
3.28xvs Diagnostics & Research peers
Price to Book (MRQ)
3.15xvs Diagnostics & Research peers
Enterprise to Revenue
3.64xvs Diagnostics & Research peers
Enterprise to EBITDA
114.54xvs Diagnostics & Research peers
Gross Margin
45.56%vs Diagnostics & Research peers
Profit Margin
-6.77%vs Diagnostics & Research peers
Operating Margin
-4.84%vs Diagnostics & Research peers
Return on Assets (TTM)
-1.89%vs Diagnostics & Research peers
Return on Equity (TTM)
-6.33%vs Diagnostics & Research peers
Revenue (TTM)
766.29MUSDvs all stocks (USD)
Revenue per Share (TTM)
5.94USDUpdated Sep 28, 2026Quarterly Revenue Growth
11.20%vs Diagnostics & Research peers
Gross Profit (TTM)
336.53MUSDvs all stocks (USD)
EBITDA (TTM)
24.32MUSDvs all stocks (USD)
Net Income (TTM)
-51.88MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
11.21%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
22.05MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
43.90MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Revenue
727.33MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
413.04MUSDFY2025 · Dec 31, 2025Gross Profit
314.29MUSDFY2025 · Dec 31, 2025Operating Income
-88.13MUSDvs all stocks (USD)
Pre-tax Income
-110.27MUSDFY2025 · Dec 31, 2025Income Tax Expense
-2.24MUSDFY2025 · Dec 31, 2025Net Income
-108.03MUSDFY2025 · Dec 31, 2025EBIT
-106.52MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-10.94MUSDFY2025 · Dec 31, 2025Research & Development
37.08MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
331.65MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
9.07MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
3.75MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.8400USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.8400USDFY2025 · Dec 31, 2025Basic Shares Outstanding
128.10MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
128.10MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-108.03MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-8.44MUSDFY2025 · Dec 31, 2025Free Cash Flow
-35.45MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
159.62MUSDFY2025 · Dec 31, 2025Income Tax Paid
515.00KUSDFY2025 · Dec 31, 2025Interest Paid
1.69MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-108.03MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
67.82MUSDFY2025 · Dec 31, 2025Stock-based Compensation
41.32MUSDFY2025 · Dec 31, 2025Other Non-cash Items
8.43MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-6.18MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-4.69MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-7.12MUSDFY2025 · Dec 31, 2025Capital Expenditures
-27.01MUSDFY2025 · Dec 31, 2025Net Acquisitions
-6.45MUSDFY2025 · Dec 31, 2025Purchase of Investments
-500.00KUSDFY2025 · Dec 31, 2025Sale of Investments
20.06MUSDFY2025 · Dec 31, 2025Other Investing Activity
1.57MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-12.34MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-201.25MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-200.29MUSDFY2025 · Dec 31, 2025Shares Outstanding
127.92MSharesUpdated Sep 28, 2026Float Shares
117.02MSharesUpdated Sep 28, 2026Shares Short
16.71MSharesUpdated Sep 28, 2026Short Ratio
10.10daysvs all stocks
Short % of Shares Outstanding
15.35%vs all stocks
% Held by Insiders
2.11%vs all stocks
% Held by Institutions
115.24%vs all stocks
Total Cash (MRQ)
145.54MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.13USDUpdated Sep 28, 2026Total Debt (MRQ)
448.37MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.5706xvs Diagnostics & Research peers
Current Ratio (MRQ)
3.60xvs Diagnostics & Research peers
Book Value per Share (MRQ)
6.14USDUpdated Sep 28, 2026Total Assets
1.36BUSDvs all stocks (USD)
Total Current Assets
376.29MUSDFY2025 · Dec 31, 2025Total Liabilities
523.27MUSDFY2025 · Dec 31, 2025Total Non-current Assets
983.54MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
434.97MUSDFY2025 · Dec 31, 2025Total Current Liabilities
88.30MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
159.62MUSDFY2025 · Dec 31, 2025Other Short-term Investments
0.00USDFY2025 · Dec 31, 2025Accounts Receivable
159.24MUSDFY2025 · Dec 31, 2025Inventory
28.57MUSDFY2025 · Dec 31, 2025Accounts Payable
23.09MUSDFY2025 · Dec 31, 2025Short-term Debt
4.78MUSDFY2025 · Dec 31, 2025Deferred Revenue
851.00KUSDFY2025 · Dec 31, 2025Long-term Debt
404.68MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
12.07MUSDFY2025 · Dec 31, 2025Common Stock (Book)
129.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-433.81MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
836.56MUSDvs all stocks (USD)
52-Week Low
7.07USDUpdated Sep 28, 202652-Week High
20.05USDUpdated Sep 28, 202652-Week Change
148.77%vs all stocks
Beta
1.75xvs all stocks
50-Day MA
16.69USDUpdated Sep 28, 2026200-Day MA
12.12USDUpdated Sep 28, 2026Avg 10-Day Volume
2.53MSharesUpdated Sep 28, 2026Avg 30-Day Volume
1.90MSharesUpdated Sep 28, 2026Diluted EPS (TTM)
-0.3900USDUpdated Sep 28, 2026Other Income / Expense
-27.46MUSDFY2025 · Dec 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Working Capital Pattern
What customers owe has grown three years running, while it clears stock quickly and pays suppliers quickly.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
Where is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.46Profit Margin: -0.07
Financial Health
Altman Z-Score 2.93: safe zoneNotable
Altman Z-Score: 2.93
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $2.48B, above the global median of $1.18BNotable
Market cap (USD): 2,483,430,255Global Median: 1,180,223,658.953
Revenue is $766.29M, above the global median of $548.88MNotable
Revenue (USD): 766,294,976Global Median: 548,883,780.48
Levered free cash flow is $43.9M, above the global median of $18.73MNotable
Levered free cash flow (USD): 43,904,752Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Autel Intelligent Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Cecep Environmental Protection Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
BGI Genomics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Belrise Industries Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Voltronic Power Technology Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Renew Energy Global Plc
Tier 1ProductionThroughput-Bound ConversionRuleFlow
DMG Mori Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Cecep Solar Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Elite Advanced Laser Corp.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Winner Medical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Iovance Biotherapeutics, Inc.
1 interpretationRevenue Growing With Receivables Growing